Fewer than 1 in 5 patients with COPD receive the recommended levels of care, with nearly 1 in 4 waiting more than 5 years to be diagnosed, research has shown. The new research, from lung charity ...
Medication nonadherence among patients with chronic obstructive pulmonary disease (COPD) is associated with increasing COPD symptoms, hospitalizations, morbidity, mortality, and health care ...
The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results